Skip to main content
. 2020 Aug 19;2020(8):CD004370. doi: 10.1002/14651858.CD004370.pub4

Marotrao 2018.

Study name Randomized trial on use of intravenous immunoglobulin in young patients with recent onset dilated cardiomyopathy
Methods Randomised, parallel‐group trial
Participants Patients < 25 years of age with dilated cardiomyopathy with left ventricular dysfunction and recent onset of symptoms (duration < 6 months)
Interventions 2 g/kg intravenous immunoglobulin over 3 days
Outcomes Improvement in left ventricular end‐diastolic dimension at 6 months; event‐free survival (i.e. death, hospitalisation, and transplant‐free survival) at 6 months
Starting date 2018
Contact information patilsuraj762@gmail.com
Notes